CRYOXPAND
LIVE

Serial Number

79331270

Owner

SITEC PHARMABIO, S.L.

Attorney

Elizabeth Lee D'Amore

Filing Date

Nov 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CRYOXPAND Trademark

Serial Number: 79331270 • Registration: 7178249

CRYOXPAND is a trademark filed by SITEC PHARMABIO, S.L. on November 10, 2021. The trademark is classified under Class 11 (Environmental Control), Class 40 (Treatment & Processing). The application is currently registered and active.

Owner Contact Info

SITEC PHARMABIO, S.L.

Parc Cientific de Barcelona,

Entity Type: 99

Trademark Details

Filing Date

November 10, 2021

Registration Date

October 3, 2023

Published for Opposition

July 18, 2023

Goods & Services

Processing of chemicals; machining parts for others, in relation to pharmaceuticals; processing of nutraceuticals; processing of chemicals for use in the production of microparticle and nanoparticle powder systems; processing of pharmaceuticals for use in the production of microparticle and nanoparticle powder systems; processing of neutraceuticals for use in the production of microparticle and nanoparticle powder systems; treatment of chemicals, transformation of chemicals, namely processing of fluids into solid, micronized powders, transformation of liquids into solid particles; processing and transformation of pharmaceuticals for others, namely, custom manufacture of pharmaceutical ingredients; treatment and transforming being custom manufacture of pharmaceutical molecules and formulations; treatment and transforming being custom manufacture of nutritional supplements; treatment and transforming of plants and medicinal herbs in the nature of distilling chemicals for others; treatment and transforming of polymeric materials in the nature of custom manufacture of polymers for chemical, pharmaceutical, food, and cosmetic uses; treatment and transforming being custom manufacture of oils and fats for fine chemical, pharmaceutical, food, and cosmetic uses; modification of particles, namely, custom production of micronized powders to be used in solid dosage forms, in liquid forms or in semisolid forms, composed of particles with specific properties of flowability, dispersibility in aqueous or oily media, and of solubility; custom production of powder preparations for the pharmaceutical, food and chemical industries; custom manufacture of microparticles and nanoparticles for chemical, pharmaceutical, food, and cosmetic uses; custom manufacture being custom manufacture of pharmaceuticals and medicines containing microparticles and nanoparticles; custom manufacture of nano-particle devices and microparticle devices for chemical, pharmaceutical, food, and cosmetic uses

Apparatus for chemical treatment, namely, heat exchangers for chemical processing; industrial treatment installations, namely, apparatus for the transformation of fluid materials into micronized powders via rapid cooling through controlled spraying of the fluid material through a nozzle and simultaneous exposure of the sprayed fluid to a flow of expanding liquid-dense carbon dioxide, contained in a spraying tower; cooling appliances and devices and installations, namely, cooling evaporator to freeze sprayed fluid material during evaporation of liquid expanding carbon dioxide; cryogenic freezers and vaporizers, in particular machines and apparatus for the crystallisation or solidification in amorphous form of substances for chemical, pharmaceutical, food or cosmetic purposes, in particular apparatus for conveying and atomising a mixture of cold, liquefied or dense gas and a substance, fluid or mixture containing gas, enabling solidification in micronised powder form; drying apparatus and installations, namely, drying apparatus for chemical processing; freeze drying equipment in the nature of apparatus and devices for removing water and drying substances at low temperature to obtain the resultant substance in micronised powder form

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 2, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 5, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 5, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 10, 2023 OPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 21, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 20, 2023 OPNS
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 8, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2023 TROA
REFUSAL PROCESSED BY IB
Nov 21, 2022 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 2, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 1, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 20, 2022 REPR